We are a fully integrated medical care company at the forefront of supportive healthcare.
Yaacob Berman
Co-Founder
Sivan Luder PhD
VP R&D and Regulatory Affairs
Jose Zuniga B.S.c
VP Operations
A clear, non-oily,non-adherent Acemannan hydrogel wound dressing for the management of burns, wounds and irritations.
AceAid Hydrogel Accelerated Wound Closure in Diabetic Foot Ulcer Patients
Data extracted from Jensen JL, et al. Adv Wound Care. 1998 Nov-Dec;11(7 Suppl):1-4
Mr. Heumann brings over 25 years of proven experience in international business management with strong abilities and success, scaling up companies and leading multidisciplinary organizations across global markets.
In the last 15 years, Mr. Heumann has been leading Digital health companies all the way from concept idea start-ups to hundreds of millions of dollars in sales, successful IPOs, and M&As. He has strong experience and expertise in operations, logistics, and supply chain, business development in the B2B & B2C markets.
Previously, Mr. Heumann served on multiple global companies in different executive roles, leading to high-performing teams, driving transformative changes in order to achieve remarkable growth and innovation.
Rafi@acemanan-tech.com
President & CEO of Natural Aloe Costa Rica since its foundation in 2010, when a group of shareholders led by Yaacov Berman acquired Carrington Labs assets in Costa Rica. From 1986-2009 Yaacov Berman was a shareholder and General Manager of Grupo ACI, a leading aquaculture company and a major exporter of fresh tilapia, mainly to the US markets.
Jose holds a Bachelor’s degree in Industrial Engineering from Univesidatd Internacional de las Americas and a Master’s in Business Administration from Universidad Latina de Costa Rica. Board member of the International Aloe Science Council and member of the Scientific Committee of the same council. With 14 years of experience from Carrington Laboratories and his current (since 2009) role as operations manager of Natural Aloe Costa Rica, Jose is responsible for AceTech’s operations.
Sivan holds a PhD in Biochemistry and MBA from Tel-Aviv University. She is highly experienced in executing and managing complex scientific projects. Sivan also holds vast knowledge and more than six years of experience in products development and regulatory affairs. Sivan oversees AceTech’s research and development activity and regulatory affairs.
Roni is an experienced business development professional in the biotech industry, with a strong background in Big-4 management consulting and a record of excellence. Roni previously held several positions at Enzymotec and at a leading digital health startup in Boston. Prior to that, she served as a Strategic Consultant Manager at EY.Roni holds a BSc (summa cum laude) in Biotechnology Engineering and an MSc in Medical Sciences, both from the Technion, as well as an MBA (cum laude) from the Open University.
roni@acemanan-tech.com
Dana holds a B.Sc.Agr in Biochemistry and Food Science from the Hebrew University of Jerusalem and a M.Sc in Molecular Genetics from Tel Aviv University. Dana has broad managerial and scientific experience, mainly in the drug development area. Together with her CRA certificate, Dana manages the marketing activities and the clinical affairs of AceTech.
dana@acemanan-tech.com
Contains Acemannan hydrogel.
Non-greasy, non-oil preparations.
Easy, no waste, application.
Can be used pre radiation therapy to condition the skin as well as for management of skin reactions post radiation therapy.
Under prescription (Rx) Only.
20z, 40z
Proportion of patients with maximal RTOG ≥2 score
RadiaAce reduced the proportion of breast cancer patients with maximal RTOG ≥2 score by 15% then gold standard
Proportion of patients with RTOG ≥2 during radiation treatment
RadiaAce was found to be 1.6 times effective in reducing high-grade radiation dermatitis two weeks after treatment